Spinraza Approved by Health Canada for Treating 5q SMA Patients
Spinraza (nusinersen) was just approved by Health Canada for the treatment of 5q spinal muscular atrophy (SMA) patients, Biogen Canada announced. This is the first therapy approved by Health Canada for the treatment of SMA. The drug is specifically indicated to treat 5q SMA, which represents about…